News
Cambridge superchip architect Arm notched record-breaking results in Q4, capping what CEO Rene Haas called ‘another great ...
Alchemab Therapeutics, whose labs are in Cambridge UK, stands to scoop $415 million from Eli Lilly and Company following a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback